These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 458333)

  • 21. [Adaptational changes in the gastrointestinal tract following jejuno-ileal bypass for obesity].
    Príkazská M; Beno I
    Radiol Diagn (Berl); 1984; 25(5):555-62. PubMed ID: 6505204
    [No Abstract]   [Full Text] [Related]  

  • 22. Release of gastric inhibitory polypeptide (GIP) and gastrin after a test meal with a low glucose load in patients after BII resection, proximal duodenopancreatectomy (PDP) and jejunoileal bypass.
    Klapdor R
    Res Exp Med (Berl); 1982; 181(1):11-8. PubMed ID: 7134635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pregnancy after jejuno-ilial bypass for morbid obesity].
    Biale Y; Ben-Aderet N; Feuchtwanger M
    Harefuah; 1978 Jan; 94(1):25-7. PubMed ID: 640501
    [No Abstract]   [Full Text] [Related]  

  • 24. [Jejuno-ileal bypass in obesity].
    Barth E; Sanderud K
    Tidsskr Nor Laegeforen; 1981 Jun; 101(16):987-9. PubMed ID: 7281115
    [No Abstract]   [Full Text] [Related]  

  • 25. [Weight loss after jejuno-ileal bypass surgery].
    Beró T; Pongrácz G; Jávor T
    Orv Hetil; 1981 Sep; 122(36):2201-4. PubMed ID: 7301380
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man.
    Burhol PG; Waldum HL; Jorde R; Lygren I
    Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Jejuno-ileal bypass in obesity].
    Ulvik NM; Helsingen N
    Tidsskr Nor Laegeforen; 1973 Mar; 93(9):570-3. PubMed ID: 4759807
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complications of jejuno-ileal bypass in the surgical treatment of obesity].
    Rubio Cerdido JM
    Rev Esp Enferm Apar Dig; 1981 Mar; 59(3):367-72. PubMed ID: 7268144
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
    Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass.
    Sirinek KR; O'Dorisio TM; Hill D; McFee AS
    Surgery; 1986 Oct; 100(4):781-7. PubMed ID: 3532392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight loss after jejuno-ileal bypass surgery.
    Beró T; Pongrácz G; Kett K; Jávor T
    Acta Med Acad Sci Hung; 1982; 39(1-2):69-77. PubMed ID: 7180362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modifications at the time of gastric secretion and gastrin incretion after jejunum-ileal bypass for obesity].
    Scopinaro N; Marugo M; Gianetta E; Civalleri D
    Minerva Chir; 1977 Dec 15-31; 32(23-24):1505-10. PubMed ID: 600444
    [No Abstract]   [Full Text] [Related]  

  • 33. [Osteopenia caused by metabolic changes following jejuno-ileal bypass for obesity].
    Príkazská M; Beno I; Makovický V; Rozhold J
    Radiol Diagn (Berl); 1984; 25(5):563-8. PubMed ID: 6505205
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in risk factors and lipids after jejuno-ileal bypass for severe obesity].
    Doldi SB; Guazzoni G; Colombo F; Strinna M; Fazio FM
    Minerva Med; 1982 Jan; 73(3-4):103-8. PubMed ID: 7058008
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tactical and technical aspects of anti-obesity jejuno-ileal bypass. Follow-up of a patient operated on 51/2 years previously].
    Martínez Díez M; Aguilella Diago V; Ingelmo Setién A; Parra Gerona MP; Martínez Ubieto F; Fuertes Lanzuela S; González González M
    Rev Esp Enferm Apar Dig; 1984 Nov; 66(5):413-23. PubMed ID: 6515098
    [No Abstract]   [Full Text] [Related]  

  • 36. [Behavior of gastric secretion and gastrin incretion in the severely obese patient treated with a jejuno-ileal shunt].
    Scopinaro N; Marugo M; Pandolfo N; Civalleri D; Giordano G
    Minerva Chir; 1976 May; 31(10):573-6. PubMed ID: 972733
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cystic pneumatosis after jejuno-ileal bypass].
    Montorsi W; Doldi SB; Tajana A
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2477. PubMed ID: 693288
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reflux and absorption in the non-functioning segment as a complication of jejuno-ileal bypass].
    Rotzinger R; O'Fárrill JB; Izé Lamache L; Gordon F
    Rev Gastroenterol Mex; 1980; 45(2):53-61. PubMed ID: 7403763
    [No Abstract]   [Full Text] [Related]  

  • 39. An antireflux valve to prevent gross abdominal distension after jejuno-ileal bypass.
    Wilson EA
    S Afr Med J; 1980 Jun; 57(24):1000-2. PubMed ID: 7404068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastric bypass in morbid obesity].
    Baltasar A; Del Rio J; Bengochea M
    Rev Clin Esp; 1980 Jun; 157(6):395-9. PubMed ID: 7414031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.